Poplar Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Boston, Massachusetts, United StatesWebsite
www.poplartx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Poplar Therapeutics
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases. Poplar is pursuing the bold idea that IgE can be rapidly driven toward zero, with the goal of helping people with IgE-mediated conditions move from fear toward freedom.Explore more
Poplar Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Poplar Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Poplar Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Poplar Therapeutics
Check if Poplar Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Poplar Therapeutics recently announced quarterly report
Poplar Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Poplar Therapeutics has new funding data
Product Launch: Get notified when Poplar Therapeutics launches new products
Click to see if Poplar Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Poplar Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Poplar Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Poplar Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Poplar Therapeutics.
Poplar Therapeutics financials insights
Gather financial insights about Poplar Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$50M
Poplar Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Poplar Therapeutics
Sign Up For FreeTo access detailed company insights
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases. Poplar is pursuing the bold idea that IgE can be... Read More
